Indivior Pharmaceuticals, Inc. (INDV) — Stock Score Summary

Indivior Pharmaceuticals, Inc. (INDV) has a MoatMap StockRank of 92/100 based on Quality (55/100), Value (47/100), and Momentum (79/100) factor scores. The current signal is STRONG BUY. Indivior specializes in buprenorphine-based treatments for opioid use disorder. While it has a niche market, it faces persistent litigation risks, antitrust challenges, and aggressive generic competition, failing our quality and durability criteria.

Indivior Pharmaceuticals, Inc. is a global pharmaceutical company focused on developing and commercializing treatments for opioid use disorder (OUD) and other serious mental health conditions. The company possesses a leading market position in the treatment of opioid dependence, particularly with its flagship product Sublocade, benefiting from intellectual property protection and established clinical efficacy. It is a dedicated pharmaceutical company addressing the opioid crisis with innovative long-acting injectable treatments.

Key Financial Metrics

Price$38.26
Market Cap$4.3B
P/E (TTM)19.21
P/E (Forward)9.55
Price/Book-31.74
Return on Invested Capital99.0%
Gross Margin85.0%
Operating Margin46.1%
Revenue Growth19.2%
Free Cash Flow$44M

Indivior Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Indivior Pharmaceuticals, Inc.’s (INDV) StockRank?
MoatMap’s StockRank for Indivior Pharmaceuticals, Inc. (INDV) is 92/100, with a Strong Buy signal. It is a composite of Quality (55), Value (47), and Momentum (79) factor ranks across MoatMap’s 19,000+ stock universe.
Does Indivior Pharmaceuticals, Inc. have an economic moat?
Indivior Pharmaceuticals, Inc. (INDV) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Indivior Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Indivior Pharmaceuticals, Inc. (INDV) is Strong Buy, based on a StockRank of 92/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Indivior Pharmaceuticals, Inc. in?
Indivior Pharmaceuticals, Inc. (INDV) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksINDV deep dive reportAI ChampionsHow we score stocksSense-check another stock